Silence Therapeutics (SLN) Gross Profit (2020 - 2025)
Silence Therapeutics' Gross Profit history spans 6 years, with the latest figure at $22000.0 for Q4 2025.
- On a quarterly basis, Gross Profit fell 99.91% to $22000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $344000.0, a 98.91% decrease, with the full-year FY2025 number at $344000.0, down 98.91% from a year prior.
- Gross Profit hit $22000.0 in Q4 2025 for Silence Therapeutics, down from $95000.0 in the prior quarter.
- Over the last five years, Gross Profit for SLN hit a ceiling of $23.3 million in Q4 2024 and a floor of -$2.6 million in Q2 2024.
- Historically, Gross Profit has averaged $3.2 million across 5 years, with a median of $1.2 million in 2021.
- Biggest five-year swings in Gross Profit: soared 343934.18% in 2021 and later crashed 241.92% in 2024.
- Tracing SLN's Gross Profit over 5 years: stood at $1.8 million in 2021, then tumbled by 42.54% to $1.1 million in 2022, then dropped by 12.05% to $934587.4 in 2023, then surged by 2389.55% to $23.3 million in 2024, then plummeted by 99.91% to $22000.0 in 2025.
- Business Quant data shows Gross Profit for SLN at $22000.0 in Q4 2025, $95000.0 in Q3 2025, and $139000.0 in Q2 2025.